Capital International Sarl Incyte Corp Transaction History

Capital International Sarl

$3.71 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $101,718 - $127,355	1,537 Added 8.92%	18,777 $1.25 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $178,421 - $224,253	2,696 Added 18.54%	17,240 $1.31 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $1.19 Million - $1.43 Million	-17,979 Reduced 55.28%	14,544 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $1.55 Million - $1.81 Million	24,443 Added 302.51%	32,523 $2.39 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $95,863 - $117,291	-1,396 Reduced 14.73%	8,080 $556,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $209,658 - $229,766	-2,625 Reduced 21.69%	9,476 $797,000
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $5,017 - $6,633	66 Added 0.55%	12,101 $983,000
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $49,412 - $59,792	612 Added 5.36%	12,035 $1.05 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $62,441 - $80,512	-734 Reduced 6.04%	11,423 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $130,408 - $191,498	1,758 Added 16.91%	12,157 $1.26 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.01 Million - $1.38 Million	-16,037 Reduced 60.66%	10,399 $762,000
Q4 2019 Feb 18, 2020	BUY	$73.04 - $95.72 $372,357 - $487,980	5,098 Added 23.89%	26,436 $2.31 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $611,688 - $726,768	-8,400 Reduced 28.25%	21,338 $1.58 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $580,808 - $700,730	-7,900 Reduced 20.99%	29,738 $2.53 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $2.34 Million - $3.24 Million	-36,800 Reduced 49.44%	37,638 $3.24 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $5.38 Million - $6.43 Million	-91,959 Reduced 55.26%	74,438 $4.73 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $204,948 - $246,369	-3,319 Reduced 1.96%	166,397 $0
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $1.33 Million - $1.84 Million	21,900 Added 14.82%	169,716 $11.4 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $5.16 Million - $6.43 Million	-55,115 Reduced 27.16%	147,816 $14 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $22.1 Million - $28.1 Million	202,931	202,931 $23.7 Million

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account